Cipla 446 Pill - red blue capsule/oblong, 23mm
Pill with imprint Cipla 446 is Red / Blue, Capsule/Oblong and has been identified as Atazanavir Sulfate 300 mg. It is supplied by Cipla USA Inc.
Atazanavir is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Cipla 446
Atazanavir Sulfate
- Imprint
- Cipla 446
- Strength
- 300 mg
- Color
- Red / Blue
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0446
- Inactive Ingredients
-
lactose monohydrate,
crospovidone,
magnesium stearate,
gelatin,
sodium lauryl sulfate,
FD&C Blue No. 1,
FD&C Red No. 3,
FD&C Red No. 40,
D&C Yellow No. 10,
titanium dioxide,
shellac,
alcohol,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
ammonia,
potassium hydroxide
Note: Inactive ingredients may vary.
More about atazanavir
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: protease inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
